Imeik Technology Development Co (300896) - Total Liabilities

Latest as of March 2026: CN¥679.01 Million CNY ≈ $99.36 Million USD

Based on the latest financial reports, Imeik Technology Development Co (300896) has total liabilities worth CN¥679.01 Million CNY (≈ $99.36 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Imeik Technology Development Co - Total Liabilities Trend (2014–2025)

This chart illustrates how Imeik Technology Development Co's total liabilities have evolved over time, based on quarterly financial data. See 300896 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Imeik Technology Development Co Competitors by Total Liabilities

The table below lists competitors of Imeik Technology Development Co ranked by their total liabilities.

Company Country Total Liabilities
Gitlab Inc
NASDAQ:GTLB
USA $686.50 Million
Godrej Industries Limited
NSE:GODREJIND
India Rs1.03 Trillion
Ming Yang Smart Energy Group Ltd
SHG:601615
China CN¥70.26 Billion
Tongcheng Travel Holdings Ltd
F:TEM
Germany €19.03 Billion
JCDECAUX SE ADR 1/2/O.N.
F:DCS0
Germany €5.78 Billion
Liaoning Port Co Ltd
SHG:601880
China CN¥12.96 Billion
Glarun Technology Co Ltd
SHG:600562
China CN¥3.45 Billion
Just Eat Takeaway
AS:TKWY
Netherlands €2.82 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down Imeik Technology Development Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Imeik Technology Development Co stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 7.21 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.09 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.07 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Imeik Technology Development Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Imeik Technology Development Co (2014–2025)

The table below shows the annual total liabilities of Imeik Technology Development Co from 2014 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥743.43 Million
≈ $108.79 Million
+90.44%
2024-12-31 CN¥390.37 Million
≈ $57.12 Million
+6.27%
2023-12-31 CN¥367.32 Million
≈ $53.75 Million
+17.44%
2022-12-31 CN¥312.77 Million
≈ $45.77 Million
+29.08%
2021-12-31 CN¥242.31 Million
≈ $35.46 Million
+72.53%
2020-12-31 CN¥140.45 Million
≈ $20.55 Million
+73.51%
2019-12-31 CN¥80.95 Million
≈ $11.84 Million
+37.51%
2018-12-31 CN¥58.87 Million
≈ $8.61 Million
-13.55%
2017-12-31 CN¥68.09 Million
≈ $9.96 Million
+40.80%
2016-12-31 CN¥48.36 Million
≈ $7.08 Million
+130.51%
2015-12-31 CN¥20.98 Million
≈ $3.07 Million
+21.76%
2014-12-31 CN¥17.23 Million
≈ $2.52 Million
--

About Imeik Technology Development Co

SHE:300896 China Medical Instruments & Supplies
Market Cap
$4.05 Billion
CN¥27.64 Billion CNY
Market Cap Rank
#4171 Global
#683 in China
Share Price
CN¥91.36
Change (1 day)
+0.48%
52-Week Range
CN¥90.92 - CN¥201.00
All Time High
CN¥570.69
About

Imeik Technology Development Co.,Ltd. engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China. The company offers aesthetic medicine products, such as cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere; poly facial implant thread; medical sodium hyaluronate-hydroxypropyl methylcellulose gel; sodium hyaluronate compos… Read more